Rakuten Medical Announces Trial in Progress Poster Presentation at ASCO 2025 and Enrollment Expansion to Taiwan for Global Phase 3 ASP-1929-381. News provided by. Rakuten Medical, Inc.

Title: A phase 1, open-label, dose escalation study on the safety and tolerability of ANK-101 in advanced solid tumors Session Type: Poster Session Session Title: Developmental Therapeutics ...

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung Cancer Congress, ELCC, 2025, taking place in Paris ...

Parabilis Medicines to Present Trial-in-Progress Poster on Phase 1/2 Study of FOG-001, ... TPS322 Presentation Date and Time: January 25, 2025, 7:00-7:55 a.m. PST Session Information: ...

Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology ... heavily pretreated myelofibrosis patient population from the Phase 2 XPORT-MF-035 trial.

In addition, a trial-in-progress poster is also being presented to highlight the ongoing pivotal Phase 2 ALPHA3 trial, which is evaluating cemacabtagene ansegedleucel (cema-cel) as part of first ...

An Italian judge has ordered Tourism Minister Daniela Santanche to stand trial on false accounting charges at a publishing group she used to own, judicial and legal sources said on Friday.

Rakuten Medical Announces Trial in Progress Poster Presentation at ASCO 2025 and Enrollment Expansion to Taiwan for Global Phase 3 ASP-1929-381 Provided by PR Newswire May 22, 2025, 11:05:00 PM ...

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager. Expect to share initial data in the first half of 2026. PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context ...

Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that it will present a Trial in Progress poster ...